Adel H. Ghiaty

发表

Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA and VRSA).

M. Seleem, Haroon Mohammad, Abdelrahman S. Mayhoub, 2017, Journal of medicinal chemistry.

Novel triazolophthalazine-hydrazone hybrids as potential PCAF inhibitors: Design, synthesis, in vitro anticancer evaluation, apoptosis, and molecular docking studies.

Hany E. A. Ahmed, Hamada S. Abulkhair, Adel H. Ghiaty, 2020, Bioorganic chemistry.

Design, synthesis, and antitumor activity of novel compounds based on 1,2,4-triazolophthalazine scaffold: Apoptosis-inductive and PCAF-inhibitory effects.

A. El-Azab, Hamada S. Abulkhair, Adel H. Ghiaty, 2020, Bioorganic chemistry.

tert-Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity

M. Seleem, Nader S. Abutaleb, A. Kotb, 2019, RSC advances.

Synthesis of novel triazoloquinoxaline‐pyrazole hybrids as antiproliferatives,EGFRinhibitors, and apoptosis inducers

M. Sarg, Adel H. Ghiaty, A. Bayoumi, 2020 .

Synthesis and Evaluation of Some New (1,2,4) Triazolo(4,3‐a)Quinoxalin‐4(5H)‐one Derivatives as AMPA Receptor Antagonists

Memy H. Hassan, Hamada S. Abulkhair, Salwa Elmeligie, 2013 .

Synthesis and evaluation of some new 1,2,4-triazolo(4,3-a)quinoxalin-4-5H-one derivatives as AMPA receptor antagonists

Memy H Hassan, Hamada S. Abulkhair, Salwa Elmeligie, 2012 .

Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity.

M. Seleem, Nader S. Abutaleb, A. Kotb, 2018, European journal of medicinal chemistry.

Design, synthesis, and molecular modelling of pyridazinone and phthalazinone derivatives as protein kinases inhibitors.

J. Bajorath, Mohamed Elagawany, S. El-feky, 2013, Bioorganic & medicinal chemistry letters.

DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL [1,2,4]TRIAZOLO[4,3-A] QUINOXALINONES

Adel Ghiaty, Adel H. Ghiaty, 2015 .

Exploration of quinoxaline derivatives as antimicrobial and anticancer agents

Shimaa M. Abd El-Gilil, Adel H. Ghiaty, A. Bayoumi, 2019, Journal of Heterocyclic Chemistry.

Synthesis and Biological Evaluation of Some [1,2,4]Triazolo[4,3-a]quinoxaline Derivatives as Novel Anticonvulsant Agents

A. El-Morsy, Adel H. Ghiaty, Kamal M El-Gamal, 2013, ISRN organic chemistry.

Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B.

Farag F. Sherbiny, Hany E. A. Ahmed, T. H. Afifi, 2020, Bioorganic chemistry.

In vivo‐ and in silico‐driven identification of novel synthetic quinoxalines as anticonvulsants and AMPA inhibitors

Memy H Hassan, Hany E. A. Ahmed, M. El-Zoghbi, 2021, Archiv der Pharmazie.

Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists

Farag F. Sherbiny, Hamada S. Abulkhair, Hany G. Ezzat, 2020, Molecular Diversity.

Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).

E. Oldfield, M. Seleem, Nader S. Abutaleb, 2018, European journal of medicinal chemistry.

Design, synthesis, and molecular docking studies of new [1,2,4]triazolo[4,3-a]quinoxaline derivatives as potential A2B receptor antagonists

Farag F. Sherbiny, Hamada S. Abulkhair, Hany G. Ezzat, 2020, Molecular Diversity.

4-Substituted benzenesulfonamides featuring cyclic imides moieties exhibit potent and isoform-selective carbonic anhydrase II/IX inhibition.

C. Supuran, A. Nocentini, P. Gratteri, 2019, Bioorganic chemistry.

From triazolophthalazines to triazoloquinazolines: A bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity.

M. El-Zoghbi, Hamada S. Abulkhair, A. A. Al-karmalawy, 2021, Bioorganic & medicinal chemistry.

Biphenylthiazole antibiotics with an oxadiazole linker: An approach to improve physicochemical properties and oral bioavailability.

M. Seleem, Haroon Mohammad, Abdelrahman S. Mayhoub, 2018, European journal of medicinal chemistry.

1,2,4-Triazolo[4,3-c]quinazolines: a bioisosterism-guided approach towards the development of novel PCAF inhibitors with potential anticancer activity

Hany E. A. Ahmed, M. El-Zoghbi, Khaled El-Adl, 2021 .

Synthesis and antiproliferative effects of 5,6-disubstituted Pyridazin-3(2H)-ones designed as conformationally constrained combretastatin A-4 Analogues.

F. Bihel, J. Bourguignon, M. Schmitt, 2013, Anti-cancer agents in medicinal chemistry.